Biotechnology in Belgium

Summary

Datamonitor's Biotechnology in Belgium industry profile is an essential resource for top-level data and analysis covering the biotechnology industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

• Contains an executive summary and data on value, volume and/or segmentation
• Provides textual analysis of the industry's recent performance and future prospects
• Incorporates in-depth five forces competitive environment analysis and scorecards

• Includes a five-year forecast of the industry
• The leading companies are profiled with supporting key financial metrics

• Supported by the key macroeconomic and demographic data affecting the market

Highlights

• Detailed information is included on market size, measured by value and/or volume

• Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape

Why you should buy this report

• Spot future trends and developments

• Inform your business decisions

• Add weight to presentations and marketing materials

• Save time carrying out entry-level research

Market Definition

The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2007 annual average exchange rates.

For the purpose of this report the Americas comprises Brazil, Canada, Mexico and the US.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

The global figure comprises the Americas, Asia-Pacific and Europe.

Contents

• Executive Summary
• Chapter 1 Market Overview
  • 1.1 Market Definition
  • 1.2 Research Highlights
  • 1.3 Market Analysis
• Chapter 2 Market Value
• Chapter 3 Market Segmentation I
• Chapter 4 Market Segmentation Ii
• Chapter 5 Five Forces Analysis
  • 5.1 Summary
  • 5.2 Buyer Power
  • 5.3 Supplier Power
  • 5.4 New Entrants
  • 5.5 Substitutes
  • 5.6 Rivalry
• Chapter 6 Leading Companies
  • 6.1 Glaxosmithkline Plc
  • 6.2 Ucb Group
  • 6.3 Amgen Inc
  • 6.4 Innogenetics N V
• Chapter 7 Market Forecasts
  • 7.1 Market Value Forecast
• Chapter 8 Demographics
• Chapter 9 Appendix
  • 9.1 Methodology
  • 9.2 Related Datamonitor Research
• List Of Tables
  • Table 1: Belgium Biotechnology Market Value: $ Million, 2003-2007
  • Table 2: Belgium Biotechnology Market Segmentation I: % Share, By Value, 2007
  • Table 3: Belgium Biotechnology Market Segmentation Ii: % Share, By Value, 2007
  • Table 1: Key Facts: Glaxosmithkline Plc
  • Table 2: Key Financials: Glaxosmithkline Plc
  • Table 3: Key Facts: Ucb Group
  • Table 4: Key Financials: Ucb Group
  • Table 5: Key Facts: Amgen Inc
  • Table 6: Key Financials: Amgen Inc
  • Table 7: Key Facts: Innogenetics N V
  • Table 8: Key Financials: Innogenetics N V
  • Table 9: Belgium Biotechnology Market Value Forecast: $ Million, 2007-2012
  • Table 10: Belgium Size Of Population (Million) , 2003-2007
  • Table 11: Belgium Gdp (Constant 2000 Prices, $ Billion), 2003-2007
  • Table 12: Belgium Inflation, 2003-2007
  • Table 13: Belgium Exchange Rate, 2003